Profusa (PFSA) Net Shares Issued and Repurchased (2025 - 2026)
Profusa's (PFSA) quarterly Net Shares Issued and Repurchased came in at $144.0 in Q1 2026, down 98.0% quarter-over-quarter from $7194.0 in Q4 2025.
Powered by 
Analysis
Profusa (PFSA) Net Shares Issued and Repurchased (2025 - 2026) Analysis & Trends
Profusa (PFSA) has reported Net Shares Issued and Repurchased for 2 consecutive years, with $144.0 the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Net Shares Issued and Repurchased changed N/A year-over-year to $144.0; the trailing twelve-month figure through Mar 2026 stood at $144.0 (changed N/A YoY), and the FY2025 full-year result was $7194.0, changed N/A from the prior year.
- Net Shares Issued and Repurchased retreated to $144.0 in Q1 2026 per PFSA's latest filing, from $7194.0 in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $7194.0 in Q4 2025 and bottomed at $144.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 178.25 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.18 Bn | 118.97 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.18 Bn | 109.36 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.54 Bn | 101.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.34 Bn | 65.80 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.64 Bn | 45.39 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.93 Bn | 32.47 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.20 Bn | 30.25 Bn | 830.00 Mn | - |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn | - |
| 10 | Profusa | 141,502.29 | -577,497.71 | - | - |